Coating-dependent induction of cytotoxicity and genotoxicity of iron oxide nanoparticles

References

• Ahamed M, Karns M, Goodson M, Rowe J, Hussain SM, Schlager JJ, Hong Y. 2008. DNA damage response to different surface chemistry of silver nanoparticles in mammalian cells. Toxicol Appl Pharmacol 233:404–10
   PubMed Web of Science ®Google Scholar
• Auffan M, Decome L, Rose J, Orsiere T, De Meo M, Briois V, et al. 2006. In vitro interactions between DMSA-coated maghemite nanoparticles and human fibroblasts: a physicochemical and cyto-genotoxical study. Environ Sci Technol 40:4367–73
   PubMed Web of Science ®Google Scholar
• Berry CC, Wells S, Charles S, Aitchison G, Curtis AS. 2004. Cell response to dextran-derivatised iron oxide nanoparticles post internalisation. Biomaterials 25:5405–13
   PubMed Web of Science ®Google Scholar
• Binns C, Maher MJ, Pankhurst QA, Kechrakos D, Trohidou KN. 2002. Magnetic behavior of nanostructured films assembled from preformed Fe clusters embedded in Ag. Phys Rev B 66:184413;1--12
   Web of Science ®Google Scholar
• Brunauer S, Emmett P, Teller E. 1938. Adsorption of gases in multimolecular layers. J Am Chem Soc 60:309--19
   Web of Science ®Google Scholar
• Cengelli F, Maysinger D, Tschudi-Monnet F, Montet X, Corot C, Petri-Fink A, et al. 2006. Interaction of functionalized superparamagnetic iron oxide nanoparticles with brain structures. J Pharmacol Exp Ther 318:108–16
   PubMed Web of Science ®Google Scholar
• Di Virgilio AL, Reigosa M, Arnal PM, Fernández Lorenzo de Mele M. 2010. Comparative study of the cytotoxic and genotoxic effects of titanium oxide and aluminium oxide nanoparticles in Chinese hamster ovary (CHO-K1) cells. J Hazard Mater 177:711–8
   PubMed Web of Science ®Google Scholar
• Fenech M. 2007. Cytokinesis-block micronucleus cytome assay. Nat Protoc 2:1084–104
   PubMed Web of Science ®Google Scholar
• Guadagnini R, Halamoda Kenzaoui B, Cartwright L, Pojana G, Magdolenova Z, Bilanicova D, et al. 2015. Toxicity screenings of nanomaterials: challenges due to interference with assay processes and components of classic in vitro tests. Nanotoxicology 9(S1):13–24
   Google Scholar
• Guardia P, Batlle-Brugal B, Roca AG, Iglesias O, Morales MP, Serna CJ, et al. 2007. Surfactant effects in monodisperse magnetite nanoparticles of controlled size. J Magn Magn Mater 316:756–9
   Web of Science ®Google Scholar
• Harris G, Palosaari T, Magdolenova Z, Mennecozzi M, Gineste JM, Saavedra L, et al. 2015. Iron oxide nanoparticle toxicity testing using high throughput analysis and high content imaging. Nanotoxicology 9(S1):87–94
   Google Scholar
• Jain TK, Richey J, Strand M, Leslie-Pelecky DL, Flask CA, Labhasetwar V. 2008. Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging. Biomaterials 29:4012–21
   PubMed Web of Science ®Google Scholar
• Kain J, Karlsson HL, Möller L. 2012. DNA damage induced by micro- and nanoparticles – interaction with FPG influences the detection of DNA oxidation in the comet assay. Mutagenesis 27:491–500
   PubMed Web of Science ®Google Scholar
• Karlsson HL. 2010. The comet assay in nanotoxicology research. Anal Bioanal Chem 398:651–66
   PubMed Web of Science ®Google Scholar
• Karlsson HL, Cronholm P, Gustafsson J, Möller L. 2008. Copper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubes. Chem Res Toxicol 21:1726–32
   PubMed Web of Science ®Google Scholar
• Karlsson HL, Gustafsson J, Cronholm P, Möller L. 2009. Size-dependent toxicity of metal oxide particles – a comparison between nano- and micrometer size. Toxicol Lett 188:112–8
   PubMed Web of Science ®Google Scholar
• Kenzaoui BH, Bernasconi CC, Hofmann H, Juillerat-Jeanneret L. 2012a. Evaluation of uptake and transport of ultrasmall superparamagnetic iron oxide nanoparticles by human brain-derived endothelial cells. Nanomedicine 7:39–53
   PubMed Web of Science ®Google Scholar
• Kenzaoui BH, Vilà MR, Miquel JM, Cengelli F, Juillerat-Jeanneret L. 2012b. Evaluation of uptake and transport of cationic and anionic ultrasmall iron oxide nanoparticles by human colon cells. Int J Nanomedicine 7:1275–86
   PubMed Web of Science ®Google Scholar
• Kim EH, Ahn Y, Lee HS. 2007. Biomedical applications of superparamagnetic iron oxide nanoparticles encapsulated within chitosan. J Alloys Compd 434/435:633–6
   Web of Science ®Google Scholar
• Magdolenova Z, Bilaničová D, Pojana G, Fjellsbø LM, Hudecova A, Hasplova K, et al. 2012a. Impact of agglomeration and different dispersions of titanium dioxide nanoparticles on the human related in vitro cytotoxicity and genotoxicity. J Environ Monit 14:455–64
   PubMed Web of Science ®Google Scholar
• Magdolenova Z, Lorenzo Y, Collins A, Dusinska M. 2012b. Can standard genotoxicity tests be applied to nanoparticles? J Toxicol Environ Health A 75:800–6
   PubMed Web of Science ®Google Scholar
• Magdolenova Z, Collins A, Kumar A, Dhawan A, Stone V, Dusinska M. 2014. Mechanisms of genotoxicity. A review of in vitro and in vivo studies with engineered nanoparticles. Nanotoxicology 8:233–278
   Google Scholar
• McNeil SE. 2005. Nanotechnology for the biologist. J Leukoc Biol 78:585–94
   PubMed Web of Science ®Google Scholar
• Monopoli MP, Walczyk D, Lowry-Campbell A, Elia G, Lynch I, Baldelli Bombelli F, Dawson KA. 2011. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc 133:2525–34
   PubMed Web of Science ®Google Scholar
• Olive PL, Banáth JP. 1995. Sizing highly fragmented DNA in individual apoptotic cells using the comet assay and a DNA crosslinking agent. Exp Cell Res 221:19–26
   PubMed Web of Science ®Google Scholar
• Schütz CA, Juillerat-Jeanneret L, Mueller H, Lynch I, Riediker M; NanoImpactNet Consortium. 2013a. Therapeutic nanoparticles in clinics and under clinical evaluation. Nanomedicine 8:449--67
   Google Scholar
• Schütz CA, Juillerat-Jeanneret L, Soltmann C, Mueller H. 2013b. Toxicity data of therapeutic nanoparticles in patent documents. World Patent Information 35:110--14
   Google Scholar
• Stone V, Johnston H, Schins RP. 2009. Development of in vitro systems for nanotoxicology: methodological considerations. Crit Rev Toxicol 39:613–26
   PubMed Web of Science ®Google Scholar
• Taupitz M, Schmitz S, Hamm B. 2003. Superparamagnetic iron oxide particles: current state and future development. Rofo 175:752–65
   PubMedGoogle Scholar
• Tulinska J, Kazimirova A, Kuricova M, Barancokova M, Liskova A, Neubauerova E, et al. 2015. Immunotoxicity and genotoxicity testing of PLGA-PEO nanoparticles in human blood cell model. Nanotoxicology 9(S1):33–43
   Google Scholar
• Wu W, Chen B, Cheng J, Wang J, Xu W, Liu L, et al. 2010. Biocompatibility of Fe3O4/DNR magnetic nanoparticles in the treatment of hematologic malignancies. Int J Nanomedicine 5:1079–84
   PubMed Web of Science ®Google Scholar
• Yin H, Casey PS, McCall MJ, Fenech M. 2010. Effects of surface chemistry on cytotoxicity, genotoxicity, and the generation of reactive oxygen species induced by ZnO nanoparticles. 21. Langmuir 26:15399–408
   PubMed Web of Science ®Google Scholar
• Yin H, Too HP, Chow GM. 2005. The effects of particle size and surface coating on the cytotoxicity of nickel ferrite. Biomaterials 26:5818–26
   PubMed Web of Science ®Google Scholar
• Ying E, Hwang HM. 2010. In vitro evaluation of the cytotoxicity of iron oxide nanoparticles with different coatings and different sizes in A3 human T lymphocytes. Sci Total Environ 408:4475–81
   PubMed Web of Science ®Google Scholar
• Zhang L, He R, Gu HC. 2006. Oleic acid coating on the monodisperse magnetite nanoparticles. Appl Surf Sci 253:2611–17
   Web of Science ®Google Scholar